Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials
ConclusionIn three large MRA RCTs, women were substantially different from men with regard to their clinical features and event rates. Nonetheless, this meta ‐analysis supports a consistent and beneficial MRA effect regardless of sex.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Xavier Rossello,
Jo ão Pedro Ferreira,
Stuart J. Pocock,
John J.V. McMurray,
Scott D. Solomon,
Carolyn S.P. Lam,
Nicolas Girerd,
Bertram Pitt,
Patrick Rossignol,
Faiez Zannad Tags: Research Article Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Heart | Heart Failure | Spironolactone | Study | Women